Table 5.

Relationship (Spearman’s correlation coefficients) between changes in BP (between Visit 1 and 2) and changes in echocardiographic parameters after 6 months in eplerenone-treated and in placebo group. Statistically significant correlations are marked in bold.

	Group	LVEDD	IVSd	PWd	LVMI	LVM	RWT
Day-Time SBP	EPL	0.38	0.14	0.05	0.29	0.32	−0.17
	SAT	−0.04	−0.01	−0.06	−0.02	−0.01	0.00
Day-Time DBP	EPL	0.02	0.08	−0.12	0.02	0.05	−0.12
	SAT	0.26	0.02	0.13	0.18	0.21	−0.06
Day-Time MAP	EPL	0.15	0.11	−0.11	0.10	0.13	−0.20
	SAT	0.21	0.02	0.02	0.11	0.14	−0.09
Night-time SBP	EPL	0.17	0.12	0.12	0.23	0.24	0.02
	SAT	−0.32	0.07	0.03	−0.29	−0.30	0.17
Night-Time DBP	EPL	0.15	0.22	0.09	0.21	0.24	0.02
	SAT	0.18	−0.04	0.39	0.31	0.29	0.28
Night-Time MAP	EPL	0.19	0.18	0.12	0.23	0.26	0.01
	SAT	−0.05	0.01	0.36	0.12	0.11	0.37
24-h SBP	EPL	0.34	0.03	−0.10	0.18	0.20	−0.28
	SAT	−0.02	−0.15	−0.07	−0.02	−0.03	−0.10
24-h DBP	EPL	−0.08	−0.07	−0.13	−0.10	−0.07	−0.09
	SAT	0.12	−0.10	0.03	−0.05	−0.03	0.02
24-h MAP	EPL	0.04	−0.04	−0.15	−0.02	−0.01	−0.17
	SAT	0.06	−0.18	−0.16	−0.13	−0.11	−0.17
NBPF	EPL	−0.12	−0.15	−0.17	−0.19	−0.21	−0.12
	SAT	0.10	−0.16	−0.03	−0.03	−0.02	−0.11